Table 3.
Unweighted 30-days, 12-month, and lifetime prevalencea of mental disorders among male students.
| 30 days prevalence |
12-month prevalence |
Lifetime prevalence |
||||
|---|---|---|---|---|---|---|
| % (95% CI) | Frequency (valid observations) | % (95% CI) | Frequency (valid observations) | % (95% CI) | Frequency (valid observations) | |
| Mood disorders | ||||||
| Major depressive episode | 10.8% (9.75%, 12.0%) | 331 (3059) | 24.7% (23.2%, 26.3%) | 754 (3049) | 34.0% (32.3%, 35.7%) | 1037 (3050) |
| Anxiety disorders | ||||||
| Any anxiety disorder | 14.3% (13.0%, 15.6%) | 423 (2967) | 21.6% (20.1%, 23.1%) | 630 (2922) | 28.0% (26.3%, 29.6%) | 819 (2930) |
| Generalized anxiety disorder | 8.2% (7.30%, 9.30%) | 250 (3032) | 13.0% (11.8%, 14.3%) | 384 (2949) | 16.9% (15.6%, 18.3%) | 498 (2949) |
| Agoraphobia | 0.7% (0.47%, 1.13%) | 22 (2983) | 1.0% (0.69%, 1.45%) | 30 (2983) | 1.3% (0.94%, 1.80%) | 39 (2983) |
| Panic disorder | 2.4% (1.86%, 2.98%) | 71 (3011) | 6.0% (5.17%, 6.90%) | 180 (3011) | 8.7% (7.76%, 9.81%) | 263 (3011) |
| Social anxiety disorder | 4.9% (4.21%, 5.80%) | 147 (2972) | 7.1% (6.25%, 8.13%) | 212 (2972) | 8.8% (7.86%, 9.94%) | 263 (2972) |
| Specific phobia | 3.0% (2.45%, 3.71%) | 90 (2982) | 4.2% (3.48%, 4.95%) | 124 (2982) | 5.9% (5.13%, 6.86%) | 177 (2982) |
| Substance-use disorder | ||||||
| Any substance-use disorder | 8.6% (7.62%, 9.69%) | 251 (2918) | 15.1% (13.8%, 16.5%) | 441 (2918) | 22.1% (20.6%, 23.6%) | 645 (2920) |
| Alcohol use disorder | 7.7% (6.77%, 8.73%) | 228 (2963) | 10.4% (9.33%, 11.6%) | 308 (2963) | 18.6% (17.3%, 20.1%) | 552 (2963) |
| Drug use disorder | 1.3% (0.91%, 1.76%) | 37 (2916) | 6.2% (5.37%, 7.16%) | 181 (2916) | 6.2% (5.37%, 7.16%) | 181 (2916) |
| Any disorder | 25.7% (24.2%, 27.4%) | 751 (2918) | 42.5% (40.7%, 44.3%) | 1240 (2916) | 53.6% (51.7%, 55.4%) | 1573 (2937) |
a
Prevalences are based on the number of female students with valid responses on the diagnostic section of interest.